Nano Medicine Committee
Annual Symposium Synopsys
Nanotechnology has the potential to have a revolutionary impact on modern
medicine, not only through the development of novel diagnosis and imaging
methods, but also through targeted therapies. It is universally accepted that
early detection of disease is essential even before anatomic anomalies are
visible. A major challenge in diagnostics in the 21st century is to
be able to determine the exact relationship between biomarkers and the clinical
pathology, as well as, to be able to non-invasively detect diseases at an early
stage for maximum therapeutic benefit.
Imaging, a critically important tool in life sciences is benefiting from the
advances in the development of nano scale particles and systems that improve and
extend the capabilities of imaging techniques. These include novel contrast
agents, quantum dot markers, engineered ligands, and smart particles that enable
imaging down to the cellular, and molecular scales with higher selectivity and
signals that previously possible.
In future nano medical therapy, targeting and localized delivery are the key
challenges. To wage an effective war against disease, we have to have the
ability to selectively target the diseased cells, while saving the normal tissue
from excessive burdens of drug toxicity. However, because many drugs are
systemic in the delivery, the distribution of drugs in healthy organs or tissues
is especially undesirable due to the potential for side effects. Consequently,
systemic application of these drugs often causes severe side effects in other
tissues (e.g. cardiomyopathy, neurotoxicity), which greatly limits the maximal
allowable dose of the drug.
This symposium will address the potential ways in which nanotechnology can
address these challenges. Distinguished speakers will summarize the current
state of the art and future barriers. Contributions are also solicited in the
following topics.
Topics & Application Areas
- Basic Science
- Clinical Science
- Commercialization
- Regulating Neural Cell Properties
- Diagnostics
- Drug Delivery to Nervous System
- Ethical / Medico-Legal Aspects
|
- Nano-Neural Interfaces & Prosthesis
- Genetics
- Modeling of Nanoscale Neuroscience
- Legal Complexity
- Pharmacology
- Regulatory
- Health & Toxicology
|
Submit Proposal or Comment to Committee Chair
We encourage you to participate and to submit your interest as either an
Scientific Committee Member or to organize a Scientific Committee*. The
NSTI will provide the infrastructure for each Industrial Committee to
organize and present a focused Symposium at the annual Nanotech
Conference and Trade Show (Nanotech 2008,
Boston, Massachusetts, June 1-5, 2008). Details will be provide upon approval of
proposal.
* All submissions will be reviewed by the NSTI Scientific Committee
Chairs and a timely response will be issued.
Back to NSTI Scientific Leadership Committees
|